trending Market Intelligence /marketintelligence/en/news-insights/trending/9ffcxjtbi_tyj4sl9gnn0g2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Rennova Health prices preferred stock offering

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Rennova Health prices preferred stock offering

Rennova Health Inc. priced an underwritten public offering of 12,350 shares of its series H convertible preferred stock at $1,000 per share.

Each preferred share is convertible into 11,111 common shares at a conversion price of 9 cents per share.

Rennova Health expects the offering to generate $12.4 million in gross proceeds before deducting underwriting discounts and commissions and other estimated offering expenses.

About $8.3 million of the net proceeds will be used to redeem certain outstanding shares of the company's series G convertible preferred stock.

The offering is expected to close Dec. 20.

Aegis Capital Corp. is acting as the sole book-running manager for the offering.